Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Queensland Health
Cerilliant
Healthtrust
Cantor Fitzgerald
Farmers Insurance
QuintilesIMS
Teva
Fish and Richardson
Harvard Business School

Generated: February 21, 2018

DrugPatentWatch Database Preview

Lidocaine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for lidocaine and what is the scope of lidocaine freedom to operate?

Lidocaine
is the generic ingredient in forty-four branded drugs marketed by Astrazeneca, Noven, Carlisle, Alkem Labs Ltd, Amneal Pharms, Belmora Llc, Fougera Pharms Inc, Glenmark Pharms Ltd, Riconpharma Llc, Septodont Inc, Taro, Teligent Pharma Inc, Teva Pharms Usa, Vitruvias Therap, Actavis Labs Ut Inc, Mylan Technologies, Teikoku Pharma Usa, Akorn, Abbott, Abraxis Pharm, Aurobindo Pharma Ltd, Bel Mar, Dell Labs, Elkins Sinn, Gd Searle Llc, Hospira, Intl Medication, Luitpold, Luitpold Pharms Inc, Lyphomed, Miles, Mylan Labs Ltd, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Baxter Hlthcare, B Braun, Fresenius Kabi Usa, Pharmaton, Meridian Medcl Techn, Dentsply Pharm, Bionpharma Inc, Sagent Pharms, G And W Labs Inc, Watson Labs Inc, Oak Pharms, Hi Tech Pharma, Wockhardt Bio Ag, Actavis Mid Atlantic, Vintage, Kendall Il, Paco, Powder Pharms, Pfizer, Fougera Pharms, Tolmar, Taro Pharms, and Galen Specialty, and is included in one hundred and twenty-nine NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for lidocaine. Thirty-four suppliers are listed for this compound.
Pharmacology for lidocaine
Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for lidocaine

US Patents and Regulatory Information for lidocaine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa XYLOCAINE lidocaine hydrochloride INJECTABLE;INJECTION 006488-010 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
B Braun LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 018967-003 Mar 30, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 088331-001 May 17, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% lidocaine hydrochloride INJECTABLE;INJECTION 083158-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bel Mar LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 080710-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride JELLY;TOPICAL 040433-001 Feb 12, 2003 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dell Labs LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 083387-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 018461-004 Feb 22, 1982 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Tolmar LIDOCAINE AND PRILOCAINE lidocaine; prilocaine CREAM;TOPICAL 076320-001 Aug 27, 2003 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hi Tech Pharma LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride SOLUTION;ORAL 040014-001 Jul 10, 1995 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for lidocaine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Noven DENTIPATCH lidocaine FILM, EXTENDED RELEASE;BUCCAL 020575-001 May 21, 1996 ➤ Sign Up ➤ Sign Up
Noven DENTIPATCH lidocaine PATCH;TOPICAL 020575-002 May 21, 1996 ➤ Sign Up ➤ Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ➤ Sign Up ➤ Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ➤ Sign Up ➤ Sign Up
Noven DENTIPATCH lidocaine PATCH;TOPICAL 020575-002 May 21, 1996 ➤ Sign Up ➤ Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ➤ Sign Up ➤ Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ➤ Sign Up ➤ Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ➤ Sign Up ➤ Sign Up
Noven DENTIPATCH lidocaine PATCH;TOPICAL 020575-002 May 21, 1996 ➤ Sign Up ➤ Sign Up
Noven DENTIPATCH lidocaine FILM, EXTENDED RELEASE;BUCCAL 020575-001 May 21, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Accenture
Fuji
Cerilliant
UBS
QuintilesIMS
Queensland Health
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot